Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti
    e2016057
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.057
    4490
    PDF: 1165
    HTML: 1443
  • INFECTIOUS COMPLICATIONS AFTER UMBILICAL CORD-BLOOD TRANSPLANTATION FROM UNRELATED DONORS

    Juan Montoro, Jaime Sanz
    e2016051
    2016-10-18
    https://doi.org/10.4084/mjhid.2016.051
    3413
    PDF: 1030
    HTML: 1569
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    4550
    PDF: 3730
    HTML: 372
  • Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with indolent behaviour

    Luca Guarnera, Valentina Boldrini, Gianmario Pasqualone, Carolina Cimino, Elisa Meddi, Roberta Laureana, Donata Trivigno, Giovanni Del Poeta, Alessandro Mauriello, Lucia Anemona, Massimiliano Postorino, Maria Cantonetti
    e2022006
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.006
    1723
    PDF: 682
    HTML: 364
  • DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse

    xinchen fang, Zimin Sun, Huilan Liu, Xiang Wan, Wen Yao, Kaidi Song, Kaidi Song, Baolin Tang, Xiaoyu zhu, Jun Peng
    e2021005
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.005
    1462
    PDF: 587
    HTML: 236
  • FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

    Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca
    e2025057
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.057
    3017
    PDF: 1053
    HTML: 1242
  • Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

    Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
    e2012018
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.018
    1687
    PDF: 845
    HTML: 1248
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1260
    PDF: 625
    HTML: 6918
  • IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

    Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria
    e2024060
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.060
    2490
    PDF: 1933
    HTML: 172
  • Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

    Giuseppe Visani, Paola Picardi, Barbara Guiduccu, Claudio Giardini, Moira Lucesole, Sara Barulli, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori
    e2013029
    2013-04-15
    https://doi.org/10.4084/mjhid.2013.029
    1529
    PDF: 868
    HTML: 1257
  • HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS

    Arturo Gonzalez Quintela, Emilio Paez-Guillan, Joaquin Campos-Franco, Rosario Alende
    e2023023
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.023
    2272
    HTML: 647
    PDF: 1385
  • Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

    Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano
    e2021054
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.054
    1315
    PDF: 481
    HTML: 223
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1518
    PDF: 778
    HTML: 259
  • LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

    Fabian Herrera
    e2024039
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.039
    1591
    PDF: 1059
    HTML: 136
  • BONE MARROW HOMING AND ENGRAFTMENT DEFECTS OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

    Giovanni Caocci, Giorgio La Nasa
    e2017032
    2017-04-19
    https://doi.org/10.4084/mjhid.2017.032
    3679
    PDF: 1613
    HTML: 3086
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    3283
    PDF: 964
    HTML: 2991
  • PRENATAL DIAGNOSIS OF ?-THALASSEMIAS AND HEMOGLOBINOPATHIES

    Maria Cristina Rosatelli, Luisella Saba
    e2009011
    2009-11-15
    1645
    PDF: 388
    HTML: 6515
  • Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19

    Fehmi Hindilerden, Ipek Yonal-Hindilerden, Emre Akar, Zuhal Yesilbag, Kadriye Kart-Yasar
    e2020053
    2020-09-14
    https://doi.org/10.4084/mjhid.2020.053
    3371
    PDF: 1617
    HTML: 284
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    2424
    PDF: 1773
    HTML: 981
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    615
    PDF: 497
    HTML: 149
  • Acute Cytomegalovirus infection as a cause of venous thromboembolism

    Raffaella Lissandrin, Francesco Mojoli, Fausto Baldanti, Enrico Brunetti, Michela Pascarella, Maria Teresa Giordani, Francesca Rinaldi
    e2014041
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.041
    1631
    PDF: 879
    HTML: 1081
    Picture 1: 190
  • CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

    Edoardo Olivari
    e2025079
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.079
    509
    PDF: 241
    Html: 108
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2556
    PDF: 1732
    HTML: 516
  • LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B

    Eva Eliassen, Gerhard R Krueger, Mario Luppi, Dharam Ablashi
    e2018035
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.035
    3843
    PDF: 1647
    HTML: 853
    Figures . Eliassian: 253
  • EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA Pediatric COVID-19 in Thailand during pre-Delta and Delta era

    Araya Satdhabudha, Chanapai Chaiyakulsil, Paskorn Sritipsukho, Phakatip Sinlapamongkolkul, Utairat Chaumrattanakul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Patcharapa Thaweekula, Amolchaya Kwankuac, Onsuthi Pharadornuwata, Tananya Lokanuwatsatiena, Pichaya Tantiyavarong, Pakarat Pranudomrata, Chatchai Mingmalairak
    e2022044
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.044
    1149
    PDF: 630
    HTML: 287
  • MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

    Maria Ilaria Del Principe
    e2016052
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.052
    5097
    PDF: 1350
    HTML: 1932
    Untitled: 209
    Untitled: 196
  • CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA

    Alessandro Bartoloni, Lorenzo Zammarchi
    e2012026
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.026
    8219
    PDF: 4435
    HTML: 7558
  • CAUSAL RELATIONSHIP BETWEEN HELICOBACTER PYLORI ANTIBODIES AND IMMUNE THROMBOCYTOPENIA: A MENDELIAN RANDOMIZATION STUDY

    Yuzhan Chen, Qitian Mu, Guifang Ouyang
    e2025.003
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.003
    1779
    PDF: 1315
    PDF: 935
    HTML: 342
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1307
    PDF: 546
    HTML: 23142
  • Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients

    Romain Fort, Guillaume Monneret, Elie Nader, Giovanna Cannas, Philippe Connes, Fabienne Venet, Arnaud Hot
    e2022078
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.078
    798
    PDF: 582
    HTML: 280
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    3072
    PDF: 1114
    HTML: 373
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1103
    PDF: 1026
    HTML: 163
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1653
    PDF: 656
    HTML: 7198
  • SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

    Firas Kreidieh, Sally Temraz
    e2020078
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.078
    1320
    PDF: 996
    HTML: 439
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3615
    PDF: 1699
    HTML: 7972
  • Cauda equina enhancing lesion in a HIV-positive patient. Case report and literature revision.

    Pasquale De Bonis, Antonella Cingolani, Angelo Pompucci, Tommaso Tartaglione, Luigi Maria Larocca, Luciana Teofili
    e2011042
    2011-10-02
    https://doi.org/10.4084/mjhid.2011.042
    1874
    PDF: 879
    HTML: 768
  • Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia

    Tuba Gullu koca, Ahmet Mert Yanik
    e2026069
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.069
    44
    PDF: 30
    Html: 5
  • THE IMPACT OF CHEMOTHERAPY AFTER PEDIATRIC MALIGNANCY ON HUMORAL IMMUNITY TO VACCINE-PREVENTABLE DISEASES

    Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro
    e2020014
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.014
    1706
    PDF: 1013
    HTML: 324
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia

    Gabriele Magliano, Andrea Bacigalupo
    e2020081
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.081
    1729
    PDF: 539
    HTML: 348
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5386
    PDF: 1995
    HTML: 2057
  • TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE

    Antonio Marzollo, Elisabetta Calore, Manuela Tumino, Marta Pillon, Maria Vittoria Gazzola, Roberta Destro, Raffaella Colombatti, Piero Marson, Tiziana Tison, Anna Colpo, Chiara Mainardi, Maria Gabelli, Maria Paola Boaro, Sara Rossin, Aurora Strano, Nadia Quaglia, Federica Menzato, Giuseppe Basso, Laura Sainati, Chiara Messina
    e2017014
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.014
    4405
    PDF: 1580
    HTML: 1253
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1348
    PDF: 768
    HTML: 1481
  • Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

    Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla
    e2018019
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.019
    2929
    PDF: 878
    HTML: 466
  • Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

    Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
    e2010035
    2010-12-13
    https://doi.org/10.4084/mjhid.2010.035
    1015
    PDF: 586
    HTML: 2222
    Cover Letter: 215
  • COMPARISON OF THE CLINICAL AND LABORATORY FEATURES OF COVID AND INFLUENZA IN CHILDREN

    Davide Pata, Danilo Buonsenso, Piero Valentini
    e2022065
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.065
    1267
    PDF: 839
    HTML: 303
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1787
    PDF: 1165
    HTML: 399
  • Systemic lupus erythematosus, complicated by nephritis and macrophage activation syndrome, not responsive to high-dose immunosuppression

    Ioanna Saougou, Alexandros Makis
    e2026054
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.054
    204
    PDF: 193
    HTML: 74
  • EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF HENOCH-SCHÖNLEIN PURPURA ASSOCIATED WITH EPSTEIN-BARR VIRUS INFECTION

    Hongbo Hu, Jiangang Wu, Ying Cheng, Jian jun Li
    e2021064
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.064
    1045
    PDF: 602
    HTML: 325
  • Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease

    Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
    e2014066
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.066
    1714
    PDF: 1039
    HTML: 1888
    Untitled: 219
    Untitled: 201
  • Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature

    Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni
    e2023028
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.028
    1087
    PDF: 822
    HTML: 427
1 - 50 of 55 items 1 2 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.